S-T Archives | Report Store | Pharma intelligence

show blocks helper

Sort by Default Order
- Default Order
- Name
- Price
- Date
- Popularity

Click to order products descending

Display 15 Products per page

Treanda/Bendeka

$10,000.00

Treanda (bendamustine; Teva/Mundipharma/Eisai) is an intravenous cytotoxic agent.
January 31, 2019
Find out more
Synflorix

$10,000.00

Synflorix (GlaxoSmithKline/Japan Vaccine) is a 10-valent pneumococcal conjugate vaccine active against Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F.
December 21, 2018
Find out more
Tyvaso

$10,000.00

United Therapeutics developed Tyvaso (treprostinil) as a follow-on product to Remodulin. As an inhaled formulation of treprostinil
October 29, 2018
Find out more
Tracleer

$10,000.00

Actelion’s Tracleer (bosentan) was the first oral therapy to be developed specifically for the treatment of pulmonary arterial hypertension (PAH).
October 29, 2018
Find out more
Selinexor

$10,000.00

Selinexor (Karyopharm/NPM Pharma) selectively inhibits the transport protein exportin-1 (XPO1), also called chromosome region maintenance-1.
October 9, 2018
Find out more
Synagis

$10,000.00

Synagis (palivizumab; AstraZeneca/AbbVie) is the global standard of care for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease.
October 5, 2018
Find out more
Symdeko

$10,000.00

Vertex’s Symdeko ([tezacaftor + ivacaftor]) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector compound
September 3, 2018
Find out more
Tobi/Tobi Podhaler

$10,000.00

Tobi and the next-generation Tobi Podhaler are the gold-standard inhaled antibiotic treatments for cystic fibrosis patients.
September 3, 2018
Find out more
Tecentriq

$10,000.00

Tecentriq (atezolizumab; Roche/Chugai) is an antibody designed to target programmed death-ligand 1 (PD-L1) on tumor cells, allowing the body’s immune system to recognize and properly respond to the tumor.
August 30, 2018
Find out more
Seribantumab

$10,000.00

Seribantumab (Merrimack Pharmaceuticals) is a monoclonal antibody directed against human epidermal growth factor receptor 3 (HER3).
August 30, 2018
Find out more
Tarceva

$10,000.00

Tarceva (erlotinib; Roche/Chugai/Astellas) is an orally available epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.
August 30, 2018
Find out more
Tafinlar

$10,000.00

Tafinlar (dabrafenib; Novartis) is an adenosine triphosphate-competitive BRAF inhibitor with more than 100-fold selectivity for mutated BRAF over wild-type.
August 30, 2018
Find out more
Thalomid

$10,000.00

Thalomid contains thalidomide, a glutamic acid derivative that possesses immunomodulatory, antiinflammatory,
and anti-angiogenic properties.
August 9, 2018
Find out more
Stelara

$10,000.00

Stelara (ustekinumab; Johnson & Johnson/Mitsubishi Tanabe) is a high-affinity, fully human monoclonal antibody that targets the p40 subunit of cytokines interleukin (IL)-12 and IL-23 proteins that occur in the immune system.
August 2, 2018
Find out more
Spiriva

$10,000.00

Spiriva (tiotropium; Boehringer Ingelheim) is a long-acting muscarinic antagonist (LAMA) approved for use in chronic obstructive pulmonary disease (COPD) and is available in a dry-powder inhaler (HandiHaler) and soft mist inhaler (Respimat) device.
July 31, 2018
Find out more

S-T

S-T

Treanda/Bendeka

Synflorix

Tyvaso

Tracleer

Selinexor

Synagis

Symdeko

Tobi/Tobi Podhaler

Tecentriq

Seribantumab

Tarceva

Tafinlar

Thalomid

Stelara

Spiriva